Characterising hypertensive disorders during pregnancy in Villavicencio, Colombia
DOI:
https://doi.org/10.18597/rcog.572Keywords:
eclampsia, preeclampsia, proteinuria, pregnancy complicationsAbstract
Objective: describing the incidence of hypertensive disorders during pregnancy in Villavicencio (Colombia) and features which may be related to complications or hospitalisation.
Materials and methods: an active search was made of hypertense pregnancies; a prospective record was kept of treatment and socio-demographic and clinical characteristics. This data was compared with institutional information regarding the pregnant population attended during the study. Hypertense group variables were compared with the presence or absence of complications and hospitalisation during this time using a multiple logistic regression model.
Results: there were 5.2% (95% CI: 4.2%-6.3%) pregnant hypertensive disorders. Comparing hypertense patients’ age and their number of gestations with the total population of pregnant women did not reveal statistically significant differences. Greater percentages of pre-term birth, assisted delivery and infant weight being below 2,500gm were found in the hypertense group. 53.2% of the cases were classified as being complicated and 15.4% of them did not receive specific treatment for this condition.
There was an association between more than 4 days’ hospitalisation with severe proteinuria and epigastralgia. Pre-term pregnancy and mild proteinuria were taken as complication predictors. Epigastralgia was used for predicting complications, having a 2.29 likelihood ratio and 0.51 negative ratio, with 0.53 Youden index.
Conclusions: hypertension during pregnancy has a great impact on maternal and perinatal health. Perinatal mortality has improved due to specialised treatment. It is suggested that preventative measures should be strengthened, as should early diagnosis and treatment of complications during pregnancy.
Author Biographies
Juan Álvaro Salazar
Juan Carlos Triana
Franklyn Edwin Prieto
References
Cunningham FG, Gant N, et al. Hypertensive disorder in pregnancy. En: Williams Obstetrics. 21st edition. New York: Mc Graw Hill; 2001. p. 567-618.
Conde-Agudelo A, Belizan JM. Risk factors for preeclampsia in a large cohort of Latin-American and Caribbean women. BJOG 2000;107:75-83.
Cifuentes R. Preeclampsia-eclampsia: diagnóstico y manejo. En: Cifuentes R. Ginecología y obstetricia basadas en las evidencias. Bogotá DC: Editorial Distribuna; 2002. P. 439-44.
Bautista A. Hipertensión y embarazo. Toxemia gravídica. En: Ñañez H, Ruiz AI, eds. Texto de Obstetricia y Perinatología. Una contribución a la enseñanza del arte, ciencia y tecnología. Bogotá DC: Pharmacia Upjohn; 1999. p 487-530.
Report of the National High Blood Pressure Education Program: Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001;344:867-72.
Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of preeclampsia. BJOG 2000; 107:1410-6.
Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997;177:1003-10.
Pridjian G, Puschett JB. Preeclampsia. Part 1: clinical and pathophysiologic considerations. Obstet Gynecol Surv 2002;57:598-618.
Chesley LC. Diagnosis of preeclampsia. Obstet Gynecol 1985;65:423-5.
Ferrazzani S, Caruso A, De Carolis S, Martino IV, Mancuso S. Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol 1990;162:366-71.
Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) much ado about nothing? Am J Obstet Gynecol 1990;162:311-6.
Ministerio de Salud. Guías de atención de las complicaciones hipertensivas asociadas al embarazo. Bogotá, DC; 2000.
Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501-9.
Martínez F, Quintero S, Zapata S. Síndrome HELLP: descripción de 100 casos en Bogotá-Colombia 1999. Rev Colomb Obstet Ginecol 2001;52:323-30.
Bautista A, Ruiz A. Síndrome HELLP un enemigo silente. En: Ñañez H, Ruiz AI, et al. Obstetricia y perinatología. Bogotá DC: Pharmacia & Upjohn; 1999. p. 487-530.
Secretaría Departamental de Salud del Meta. Enfermedades Sujetas a Vigilancia Intensificada. Villavicencio; 2003.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
